Marjon de Vos

Marjon de Vos is an Assistant Professor at the University of Groningen's Faculty of Science and Engineering, affiliated with the GELIFES (Groningen Institute for Evolutionary Life Sciences) and leading the De Vos lab - Microbial Eco-Evolutionary Medicine. Her research focuses on the ecology and evolution of bacteria from polymicrobial ecosystems, particularly in the context of antibiotic resistance and urinary tract infections. She is also actively involved in public health initiatives, serving as Vice-Chair of the Netherlands Organisation for Health Research and Development's committee on Infectious Diseases and Antibiotic Resistance, and as a Fellow of the Aletta Jacobs School of Public Health.

Education & Roles: While formal educational details are not explicitly listed, her roles include teaching BSc/MSc courses on Evolutionary Medicine and Microbiome, coordinating curricula, and holding leadership positions in national health committees. She is also a member of The Lancet Microbe's International Advisory Board.

Research Interests: Her work integrates eco-evolutionary principles to study microbial communities, emphasizing how environmental and genetic factors drive antibiotic resistance. Key themes include polymicrobial infections, antimicrobial resistance dynamics, and One Health approaches. She investigates how microbial interactions influence resistance evolution and pathogenicity, with a focus on urinary tract pathogens like Escherichia coli.

Recent Articles Overview: Her publications (2020–2025) highlight studies on plasmid evolution, metabolic interactions in microbial communities, and the role of iron regulation in pathogen toxicity. These contributions bridge fundamental research with clinical applications, such as rapid UTI diagnostics and predicting resistance evolution using regulatory networks.

• Scientific Awards:
• L'Oreal-Unesco For Women in Science Fellowship (2022)

Advising & Grants: Supervises PhD students including M. Bustamante Ordonez and L. Zandbergen. Leads projects funded by grants such as the UTIr: Urinary Tract Infections revisited (2023–2027) and AL-III: Eco-evolutionary interactions in microbial communities (2020–2024). These projects address microbial eco-evolutionary drivers of infections and resistance spread.

Labs & Teams: Directs the De Vos lab, which combines experimental microbiology, evolutionary theory, and clinical insights to tackle antimicrobial resistance. Collaborates internationally on projects like the AL-Xtra: Ecology of microbial infectious ecosystems (2018–2024).